“Given recent Centers for Medicare and Medicaid Services coverage of CTC for CRC screening, this study and its conclusions are more important than ever,” experts write. 

Founded in 2018, Positrigo scored U.S. Food and Drug Administration clearance last year for its NeuroLF brain PET system, which is targeted toward Alzheimer's. 

Researchers are hopeful that a new technology named after a tentacled folklore sea monster can help scientists better understand the anatomy of the brain. 

Though surgery is the current standard of care, experts believe ablative strategies "may become the primary choice for PTC treatment" in the future.

Former American College of Cardiology president Kim Allan Williams, Sr., MD, an ACC delegate to the American Medical Association House of Delegates, discusses an AMA resolution aimed at improving public awareness of low-dose CT lung cancer exams that can screen for coronary artery calcium at the same time. 

With prostate MRI assessments now being utilized more frequently, experts suggest AI could offer a more sustainable approach to managing growing workloads.

The uptick came during a time when the number of ED episodes increased by only 8% at the same institution, with defensive medicine one possible driver. 

The American Society of Nuclear Cardiology made its voice heard, pushing for legislation to repeal Medicare payment cuts and tie payments to inflationary increases. Prior authorization and a proposed tariff on radioisotopes were also discussed.